IL34 and Alzheimer disease: As described in the literature, the beneficial effects of IL-34 on microglia-mediated clearance of Aβ suggest that increasing IL-34 in brain regions affected in AD may provide some therapeutic value (42, 45–48, 50, 52, 53).